Utilization of inhibitors of the KQT1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites

Details for Australian Patent Application No. 2005200216 (hide)

Owner Sanofi-Aventis

Inventors Wei, Aguan; Lang, Hans Jochen; Hofmann, Joachim; Gerlach, Uwe

Agent Watermark

Pub. Number AU-A-2005200216

Parent 15595

Filing date 18 January 2005

Wipo publication date 10 February 2005

International Classifications

A61K 031/00

A61P 033/14 Antiparasitic agents

A61P 033/10 Antiparasitic agents

A01N 043/16 Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 031/352 - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 031/4433

A61K 031/18 - Sulfonamides

A61K 031/353

Event Publications

3 February 2005 Complete Application Filed

10 February 2005 Application Open to Public Inspection

  Published as AU-A-2005200216

16 August 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005200217-Polishing apparatus

2005200215-Aggregate with light-weight granular stone for the production of concrete as well as a method for its production